Xianxin Qiu

1.1k total citations
46 papers, 790 citations indexed

About

Xianxin Qiu is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xianxin Qiu has authored 46 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 18 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Xianxin Qiu's work include Glioma Diagnosis and Treatment (18 papers), Head and Neck Cancer Studies (8 papers) and Head and Neck Surgical Oncology (7 papers). Xianxin Qiu is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Head and Neck Cancer Studies (8 papers) and Head and Neck Surgical Oncology (7 papers). Xianxin Qiu collaborates with scholars based in China, United States and Singapore. Xianxin Qiu's co-authors include Jiade J. Lu, Lin Kong, Wanzun Lin, Jiyi Hu, Weixu Hu, Jing Yang, Sufang Qiu, Jing Gao, Qingting Huang and Long Chen and has published in prestigious journals such as Nature Communications, Cancer and Scientific Reports.

In The Last Decade

Xianxin Qiu

45 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianxin Qiu China 16 329 242 240 190 155 46 790
John B. Hamner United States 13 367 1.1× 169 0.7× 227 0.9× 331 1.7× 102 0.7× 27 849
Andrea Fontana Italy 19 285 0.9× 335 1.4× 238 1.0× 549 2.9× 127 0.8× 50 1.0k
Myron G. Best Netherlands 16 506 1.5× 164 0.7× 470 2.0× 339 1.8× 107 0.7× 38 988
Lidia Gatto Italy 21 326 1.0× 450 1.9× 290 1.2× 342 1.8× 334 2.2× 83 1.2k
Malaka Ameratunga Australia 14 268 0.8× 282 1.2× 133 0.6× 375 2.0× 215 1.4× 45 824
María Vieito Spain 16 273 0.8× 256 1.1× 337 1.4× 510 2.7× 189 1.2× 100 907
Elizabeth Cohen‐Jonathan Moyal France 17 328 1.0× 255 1.1× 195 0.8× 306 1.6× 508 3.3× 50 1.1k
Lars Schüttrumpf Germany 10 374 1.1× 179 0.7× 157 0.7× 216 1.1× 55 0.4× 14 785
Amélie Lusque France 16 190 0.6× 287 1.2× 210 0.9× 528 2.8× 90 0.6× 61 929
Gaspar Reynés Spain 14 371 1.1× 219 0.9× 232 1.0× 222 1.2× 472 3.0× 40 898

Countries citing papers authored by Xianxin Qiu

Since Specialization
Citations

This map shows the geographic impact of Xianxin Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianxin Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianxin Qiu more than expected).

Fields of papers citing papers by Xianxin Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianxin Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianxin Qiu. The network helps show where Xianxin Qiu may publish in the future.

Co-authorship network of co-authors of Xianxin Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianxin Qiu. A scholar is included among the top collaborators of Xianxin Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianxin Qiu. Xianxin Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Xianxin, Lei Chen, Liping Liang, et al.. (2024). CNSC-21. THE EFFICACY OF TUMOR TREATING FIELDS IN TREATING IDH-MUTANT ASTROCYTOMA, WHO GRADE 4: AN EARLY RESULT FROM SHANGHAI HUASHAN HOSPITAL. Neuro-Oncology. 26(Supplement_8). viii45–viii45.
2.
Huang, Qingting, Jiyi Hu, Weixu Hu, et al.. (2023). Preliminary clinical outcomes of head and neck squamous cell carcinoma treated with particle beam radiation therapy. Cancer Medicine. 12(11). 12128–12138. 3 indexed citations
3.
Qiu, Xianxin, Jing Gao, Jiyi Hu, et al.. (2023). Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center. Journal of Neuro-Oncology. 165(2). 241–250. 2 indexed citations
4.
Qiu, Xianxin, Jing Gao, Jiyi Hu, et al.. (2022). Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center. Journal of Neuro-Oncology. 162(3). 503–514. 2 indexed citations
5.
Lin, Wanzun, Li Chen, Xianxin Qiu, et al.. (2022). Identification of molecular subtypes based on inflammatory response in lower-grade glioma. Inflammation and Regeneration. 42(1). 29–29. 11 indexed citations
6.
Hu, Jiyi, Zhongyi Yang, Jing Gao, et al.. (2021). Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study. Annals of Translational Medicine. 10(22). 1196–1196. 1 indexed citations
7.
Guo, Jingli, Xianxin Qiu, Wenyi Tang, et al.. (2021). One-Year Efficacy and Safety of Proton-Beam Irradiation Combined with Intravitreal Conbercept for Refractory or Recurrent Polypoidal Choroidal Vasculopathy: A Pilot Study. Ophthalmology and Therapy. 11(1). 187–199. 1 indexed citations
8.
Lin, Wanzun, Yun Sun, Xianxin Qiu, et al.. (2021). VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy. Journal of Neuroinflammation. 18(1). 18 indexed citations
9.
Huang, Qingting, Weixu Hu, Jiyi Hu, et al.. (2021). Intensity-modulated proton and carbon-ion radiation therapy in the management of major salivary gland carcinomas. Annals of Translational Medicine. 10(22). 1195–1195. 4 indexed citations
10.
Huang, Qingting, Jiyi Hu, Weixu Hu, et al.. (2021). Comparison of the efficacy and toxicity of postoperative proton versus carbon ion radiotherapy for head and neck cancers. Annals of Translational Medicine. 10(22). 1197–1197. 2 indexed citations
11.
Hu, Jiyi, Qingting Huang, Jing Gao, et al.. (2021). Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 653050–653050. 7 indexed citations
12.
Lin, Wanzun, Xiaochuan Chen, Ting Chen, et al.. (2020). C1QTNF6 as a Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma. DNA and Cell Biology. 39(6). 1000–1011. 15 indexed citations
15.
Hu, Weixu, Jiyi Hu, Jing Gao, et al.. (2020). Intensity-modulated particle beam radiation therapy in the management of olfactory neuroblastoma. Annals of Translational Medicine. 8(15). 926–926. 6 indexed citations
16.
Hu, Weixu, Jiyi Hu, Qingting Huang, et al.. (2020). Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses. Frontiers in Oncology. 10. 572493–572493. 14 indexed citations
17.
Yang, Jing, Weixu Hu, Xiyin Guan, et al.. (2020). Particle Beam Radiation Therapy for Skull Base Sarcomas. Frontiers in Oncology. 10. 3 indexed citations
18.
Guan, Xiyin, Jing Gao, Jiyi Hu, et al.. (2019). The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine. Radiation Oncology. 14(1). 206–206. 31 indexed citations
19.
Kong, Lin, Jing Gao, Xianxin Qiu, et al.. (2019). Proton and Carbon-ion Radiotherapy for High Grade Glioma: Early Results of the Shanghai Proton and Heavy Ion Center (SPHIC). International Journal of Radiation Oncology*Biology*Physics. 103(5). E8–E8. 2 indexed citations
20.
Zhang, Jinfeng, Yao Chen, Xianxin Qiu, et al.. (2015). The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study. Tumor Biology. 37(3). 3797–3805. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026